0      0

DPC Summit

B104 - Offering Buprenorphine Treatment in your Direct Primary Care Practice

Jul 17, 2020 2:00pm ‐ Jul 17, 2020 3:00pm


It is the policy of the DPC Summit Co-Organizers that all individuals in a position to control content disclose any relationships with commercial interests upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflict of interest (COI), and if identified, conflicts are resolved prior to confirmation of participation. Only those participants who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this CME activity.

All faculty in a position to control content for this session have indicated they have no relevant financial relationships to disclose.

The content of this material/presentation in this CME activity will not include discussion of unapproved or investigational uses of products or devices.

By the end of this educational activity, participants should be better able to:

  1. Understand the process of how to become certified to prescribe buprenorphine and reward/benefits of offering OBOT as a primary care physician.
  2. Identify ways to incorporate OBOT (office based opioid treatment) in a Direct Primary Care practice and why a DPC practice is ideal for treating addiction.
  3. Address misconceptions around addiction treatment, particularly buprenorphine treatment.

Click here to evaluate this session and claim CME.


You must be logged in and own this session in order to post comments.